ABT sees a 21.6% jump in CGM sales and growing global diagnostics demand, while FX and macro pressure temper its outlook.

Explore the advantages of continuous glucose monitors and their reliance on precise electronic components for accurate data ...

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...

Share on Pinterest Getty Images/Dragoljub Bankovic The FreeStyle Libre is a continuous glucose monitoring (CGM) system that doesn’t require a blood sample from a finger stick. It’s ...

Abbott's steady cash flow, premium margins, and expanding diabetes and medtech franchises make it a long-term winner. See why ...

Gwyneth Paltrow has sparked health fears among fans after they spotted a worrying clue in her latest Instagram clip shared ...

The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest. The company's ...

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Thankfully, with a bit more walking and some diet changes, like swapping white bread and pasta for wholemeal and making my ...

Abbott’s FreeStyle Libre continuous glucose monitoring technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes, according ...

Abbott has officially upgraded its medical resume from glucose guru to heart hero. Its FreeStyle Libre device is now linked ...